Pages that link to "Q34204588"
Jump to navigation
Jump to search
The following pages link to Systematic review of comparative effectiveness data for oncology orphan drugs. (Q34204588):
Displaying 7 items.
- Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries (Q26748763) (← links)
- Effectiveness, safety and costs of orphan drugs: an evidence-based review (Q26827237) (← links)
- Principles for consistent value assessment and sustainable funding of orphan drugs in Europe (Q35610429) (← links)
- Systematic review of available evidence on 11 high-priced inpatient orphan drugs. (Q37116422) (← links)
- Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology. (Q47137018) (← links)
- Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties (Q59337367) (← links)
- Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review (Q64094014) (← links)